معرفی
Professor Renea Taylor is an Associate Dean in the Faculty of Medicine, Nursing and Health Sciences at Monash University, and Co-Head of the Cancer Program at the Monash Biomedicine Discovery Institute. She leads the Prostate Cancer Research Group in the Department of Physiology, specializing in translational research targeting prostate cancer. Her work focuses on hormonal regulation of stem cells, tumor microenvironment interactions, and genetic risk factors like BRCA2 mutations. She co-founded the Melbourne Urological Research Alliance (MURAL), managing Australia's largest patient-derived xenograft (PDX) collection, critical for drug development and biomarker discovery. Taylor chairs the Victorian node of the Australian Prostate Cancer Bioresource (APCB), overseeing >8,500 patient samples contributing to 120+ publications and international collaborations.
- Affiliations: Monash University, Monash Biomedicine Discovery Institute, APCB Executive Committee, MURAL
- Leadership Roles: Associate Dean, Co-Head of Cancer Program, Editorial Board positions (Endocrine Connections, The Prostate)
Her research integrates preclinical models with clinical practice, advancing therapies like CAR T-cell and PARP inhibitors. She has secured $18.1M in grants, including NHMRC and U.S. Army funding. Taylor actively mentors over 6 PhD students and advocates for women in STEM. Her community engagement includes leading the Monash Prostate Cancer Support Group and collaborating with advocacy organizations like RULE Prostate Cancer.
Scientific Leadership: Guest-edited special issues on prostate cancer biomarkers and reproductive health impacts of cancer therapies. Serves on national and international committees (ANZUP, Cancer Council Victoria).
Grants & Awards: 23+ awards including the Advancing Women’s Success Grant (2018), Dean’s Excellence in Education Award (2023), and multiple NHMRC grants. Over 107 publications with 4,450+ citations.
